IP Verse

Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression - EP2295547

The patent EP2295547 was granted to Baxalta on Sep 20, 2017. The application was originally filed on Jan 27, 2006 under application number EP10010933A. The patent is currently recorded with a legal status of "Revoked".

EP2295547

BAXALTA
Application Number
EP10010933A
Filing Date
Jan 27, 2006
Status
Revoked
Jun 28, 2019
Grant Date
Sep 20, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

APTEVO BIOTHERAPEUTICSJun 18, 2018GILL JENNINGS & EVERYADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONWO2005030039
OPPOSITIONWO2006101474
SEARCHWO2005040367

Non-Patent Literature (NPL) Citations (51) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BERKNER,K.L., "The vitamin K-dependent carboxylase", J.NUTR., (2000), vol. 130, pages 1877 - 1880, XP002204114-
DESCRIPTION- DERIAN,C.K.; VANDUSEN,W.; PRZYSIECKI,C.T.; WALSH,P.N.; BERKNER,K.L.; KAUFMAN,R.J.; FRIEDMAN,P.A., "Inhibitors of 2-ketoglutarate-dependent dioxygenases block aspartyl beta-hydroxylation of recombinant human factor IX in several mammalian expression systems", J.BIOLCHEM., (1989), vol. 264, pages 6615 - 6618-
DESCRIPTION- ESMON,C.T.; SADOWSKI,J.A.; SUTTIE,J.W., "A new carboxylation reaction. The vitamin K-dependent incorporation of H-14-C03- into prothrombin", J.BIOL.CHEM., (1975), vol. 250, pages 4744 - 4748-
DESCRIPTION- ESMON,C.T.; SUTTIE,J.W.; JACKSON,C.M., "The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin", J.BIOL.CHEM., (1975), vol. 250, pages 4095 - 4099-
DESCRIPTION- European Pharmacopeia 5. Assay of Human Coagulation Factor VII, (2005), vol. 2.7.10, page 203-
DESCRIPTION- FURIE,B.; BOUCHARD,B.A.; FURIE,B.C., "Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid", BLOOD, (1999), vol. 93, pages 1798 - 1808, XP002204113-
DESCRIPTION- KAUFMAN, R.J.; WASLEY, L.C.; FURIE, B.C.; FURIE, B.; SHOEMAKER, C.B., "Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells", J.BIOLCHEM., (1986), vol. 261, pages 9622 - 9628-
DESCRIPTION- KAUFMAN,R.J.; WASLEY,L.C.; FURIE,B.C.; FURIE,B.; SHOEMAKER,C.B., "Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells", J.BIOL.CHEM., (1986), vol. 261, pages 9622 - 9628-
DESCRIPTION- LIN, P.J.; STRAIGHT, D.L.; STAFFORD, D.W., "Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product", J.BIOI.CHEM., (2004), vol. 279, pages 6560 - 6566-
DESCRIPTION- LIN, P.J.; STRAIGHT, D.L.; STAFFORD, D.W., "Binding of the factor IX gamma-carboxyglutamic acid domain to the vitamin K-dependent gamma-glutamyl carboxylase active site induces an allosteric effect that may ensure processive carboxylation and regulate the release of carboxylated product", J.BIOL.CHEM., (2004), vol. 279, pages 6560 - 6566-
DESCRIPTION- MALHOTRA,O.P.; NESHEIM,M.E.; MANN,K.G., "The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins", J.BIOLCHEM., (1985), vol. 260, pages 279 - 287-
DESCRIPTION- MANN, K.G.; JENNY, R.J.; KRISHNASWAMY, S., "Cofactor proteins in the assembly and expression of blood clotting enzyme complexes", ANNU.REV.BIOCHEM., (1988), vol. 57, pages 915 - 956-
DESCRIPTION- MOOR, E.; SILVEIRA, A.; VAN'T HOOFT, F.; SUONTAKA, A.M.; ERIKSSON, P.; BLOMBACK, M.; HAMSTEN, A., "Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype", ARTERIOSCLER.THROMB.VASC.BIOL., (1995), vol. 15, pages 655 - 664-
DESCRIPTION- MORRISSEY, J.H.; MACIK, B.G.; NEUENSCHWANDER, P.F.; COMP, P.C., "Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation", BLOOD, (1993), vol. 81, pages 734 - 744, XP002216887-
DESCRIPTION- NELSESTUEN,G.L.; BRODERIUS,M.; MARTIN,G., "Role of gamma-carboxyglutamic acid. Cation specificity of prothrombin and factor X-phospholipid binding", J.BIOL.CHEM., (1976), vol. 251, pages 6886 - 6893-
DESCRIPTION- NELSESTUEN, G.L.; ZYTKOVICZ, T.H.; HOWARD, J.B., "The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin", J.BIOL.CHEM., (1974), vol. 249, pages 6347 - 6350-
DESCRIPTION- SCAHILL, S.J.; DEVOS, R.; VAN DER, H.J.; FIERS, W., "Expression and characterization of the product of a human immune interferon cDNA gene in Chinese hamster ovary cells", PROC.NATL.ACAD.SCI.U.S.A, (1983), vol. 80, pages 4654 - 4658-
DESCRIPTION- STENFLO,J.; SUTTIE,J.W., "Vitamin K-dependent formation of gamma-carboxyglutamic acid.", ANNU.REV.BIOCHEM., (1977), vol. 46, pages 157 - 172-
DESCRIPTION- SUTTIE,J.W., "Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid", CRC CRIT REV.BIOCHEM., (1980), vol. 8, pages 191 - 223-
DESCRIPTION- VERMEER, C.; DE BOER-VAN DEN BERG MA, "Vitamin K-dependent carboxylase", HAEMATOLOGIA, (1985), vol. 18, pages 71 - 97-
DESCRIPTION- WARE,J.; DIUGUID,D.L.; LIEBMAN,H.A.; RABIET,M.J.; KASPER,C.K.; FURIE,B.C.; FURIE,B.; STAFFORD,D.W., "Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties", J.BIOL.CHEM., (1989), vol. 264, pages 11401 - 11406-
DESCRIPTION- WASLEY, L.C.; REHEMTULLA, A.; BRISTOL, J.A.; KAUFMAN, R.J., "PACE/furin can process the vitamin K-dependent pro-factor IX precursor within the secretory pathway", J.BIOL.CHEM., (1993), vol. 268, pages 8458 - 8465-
DESCRIPTION- ZHANG,L.; JHINGAN,A.; CASTELLINO,F.J., "Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity", BLOOD, (1992), vol. 80, pages 942 - 952, XP002092839-
DESCRIPTION- HERLITSCHKA, S.E.; FALKNER, F.G.; SCHLOKAT, U.; DORNER, F., "Overexpression of human prothrombin in permanent cell lines using a dominant selection/amplification fusion marker", PROTEIN EXPR.PURIF., (1996), vol. 8, doi:doi:10.1006/prep.1996.0111, pages 358 - 364, XP002942067
DESCRIPTION- HIMLY, M.; PFLEIDERER, M.; HOLZER, G.; FISCHER, U.; HANNAK, E.; FALKNER, F.G.; DORNER, F.; 1998, "Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins", PROTEIN EXPR.PURIF., vol. 14, doi:doi:10.1006/prep.1998.0970, pages 317 - 326, XP027414782
DESCRIPTION- FURIE,B.; FURIE,B.C., "The molecular basis of blood coagulation", CELL, (1988), vol. 53, doi:doi:10.1016/0092-8674(88)90567-3, pages 505 - 518, XP023908863
DESCRIPTION- MOUNTFORD, P.S.; SMITH, A.G., "Internal ribosome entry sites and dicistronic RNAs in mammalian transgenesis", TRENDS GENET., (1995), vol. 11, doi:doi:10.1016/S0168-9525(00)89040-X, pages 179 - 184, XP005270520
DESCRIPTION- ZWAAL,R.F.; COMFURIUS,P.; BEVERS,E.M., "Lipid-protein interactions in blood coagulation", BIOCHIM.BIOPHYS.ACTA, (1998), vol. 1376, doi:doi:10.1016/S0304-4157(98)00018-5, pages 433 - 453, XP004281741
DESCRIPTION- HALLGREN, K.W.; HOMMEMA, E.L.; MCNALLY, B.A.; BERKNER, K.L., "Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: implications for the release of vitamin K-dependent proteins", BIOCHEMISTRY, (2002), vol. 41, doi:doi:10.1021/bi026016e, pages 15045 - 15055, XP002983284
DESCRIPTION- ROST, S.; FREGIN, A.; IVASKEVICIUS, V.; CONZELMANN, E.; HORTNAGEL, K.; PELZ, H.J.; LAPPEGARD, K.; SEIFRIED, E.; SCHARRER, I.; TUDD, "Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2", NATURE, (2004), vol. 427, doi:doi:10.1038/nature02214, pages 537 - 541, XP002318816
DESCRIPTION- MCGRAW, R.A.; DAVIS, L.M.; NOYES, C.M.; LUNDBLAD, R.L.; ROBERTS, H.R.; GRAHAM, J.B.; STAFFORD, D.W., "Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX", PROC.NATL.ACAD.SCI.U.S.A, (1985), vol. 82, doi:doi:10.1073/pnas.82.9.2847, pages 2847 - 2851, XP008146066
DESCRIPTION- REHEMTULLA, A.; ROTH, D.A.; WASLEY, L.C.; KULIOPULOS, A.; WALSH, C.T.; FURIE, B.; FURIE, B.C.; KAUFMAN, R.J., "In vitro and in vivo functional characterization of bovine vitamin K-dependent gamma-carboxylase expressed in Chinese hamster ovary cells", PROC.NATL.ACAD.SCI.U.S.A, (1993), vol. 90, doi:doi:10.1073/pnas.90.10.4611, pages 4611 - 4615, XP002204115
OPPOSITION- D B Mcclure, J D Walls, B W Grinnell, "Post-translational processing events in the secretion pathway of human protein C, a complex vitamin K-dependent antithrombotic factor", J. Biol. Chem., (19920925), vol. 267, no. 27, pages 19710 - 19717, XP055500295-
OPPOSITION- KAUFMAN et al., "Expression, Purification, and Characterization of Recombinant Î -Carboxylated Factor IX Synthesized in Chinese Hamster Ovary Cells", J. Biol. Chem., (19860725), vol. 261, no. 21, pages 9622 - 9628, XP001318486-
OPPOSITION- KOJIMA et al., "The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress? elucidation by GADD34-deficient mice", FASEB J, (20030000), vol. 17, no. 11, pages 1573 - 1585, XP003024669-
OPPOSITION- Satoru K Nishimoto, Price Paul A, "Secretion of the Vitamin K-dependent Protein of Bone by Rat Osteosarcoma Cells EVIDENCE FOR AN INTRACELLULAR", J. Biol. Chem., (19800725), vol. 255, no. 14, pages 6579 - 6583, XP055500287-
OPPOSITION- WALLIN R; SANE D C; HUTSON S M, "Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system", Thrombosis Research, (20030000), vol. 108, pages 221 - 226, XP002375181
OPPOSITION- HALLGREN et al., "Carboxylase overexpression effects full carboxylation but poor release and secretion of factor IX: Implications for the release of vitamin K-dependent proteins", Biochemistry, (20020000), vol. 41, pages 15045 - 15055, XP002983284
OPPOSITION- STANLEY et al., "THE PROPEPTIDES OF THE VITAMIN K-DEPENDENT PROTEINS POSSESS DIFFERENT AFFINITIES FOR THE VITAMIN K-DEPENDENT CARBOXYLASE", J. Biol. Chem., (19990601), vol. 274, no. 24, pages 16940 - 16944, XP002928626
OPPOSITION- Pen-Jen Lin, David L. Straight, Darrel W. Stafford, "Binding of the Factor IX γ-Carboxyglutamic Acid Domain to the Vitamin K-dependent γ-Glutamyl Carboxylase Active Site Induces an Allosteric Effect That May Ensure Processive Carboxylation and Regulate the Release of Carboxylated Product", J. Biol. Chem., (20040220), vol. 279, no. 8, pages 6560 - 6566, XP055500302
OPPOSITION- WAJIH et al., "Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity - Evidence for a functional CXXC redox center in the system", J. Biol. Chem., (20050107), vol. 280, no. 11, pages 10540 - 10547, XP002375189
OPPOSITION- WAJIH et al., "Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle", J. Biol. Chem., (20050719), vol. 280, no. 36, pages 31603 - 31607, XP002375182
OPPOSITION- BERKNER K L; RUNGE K W, "THE PHYSIOLOGY OF VITAMIN K NUTRITURE AND VITAMIN K-DEPENDENT PROTEIN FUNCTION IN ATHEROSCLEROSIS", J. Thrombosis & Haemostasis, (20040000), vol. 12, no. 2, pages 2118 - 2132, XP009072206
OPPOSITION- SUN YAN-MEI; ET AL, "Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X", Blood, (20050804), vol. 106, no. 12, pages 3811 - 3815, XP002377556
OPPOSITION- DOUIN et al., "Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors", BMC Biotechnology, (20040727), vol. 4, no. 1, page 16, XP021005932
SEARCH- WALLIN REIDAR ET AL, "Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.", THROMBOSIS RESEARCH, (2002), vol. 108, no. 4, ISSN 0049-3848, pages 221 - 226, XP002377557 [Y] 1-16 * abstract *
SEARCH- ROST S ET AL, "Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (20040205), vol. 427, no. 6974, ISSN 0028-0836, pages 537 - 541, XP002318816 [Y] 1-16 * abstract *
SEARCH- LI TAO ET AL, "Identification of the gene for vitamin K epoxide reductase", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (20040205), vol. 427, no. 6974, ISSN 0028-0836, pages 541 - 544, XP002318817 [Y] 1-16 * abstract *
SEARCH- WAJIH NADEEM ET AL, "Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity - Evidence for a functional CXXC redox center in the system", JOURNAL OF BIOLOGICAL CHEMISTRY, (200503), vol. 280, no. 11, ISSN 0021-9258, pages 10540 - 10547, XP002377554 [X] 1-16 * abstract * * page 10544; figure 3 * * page 10545, column R, line 6 - page 10546, column L, line 8; figure 4 *
SEARCH- WAJIH NADEEM ET AL, "Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle", JOURNAL OF BIOLOGICAL CHEMISTRY, (200509), vol. 280, no. 36, ISSN 0021-9258, pages 31603 - 31607, XP002377555 [XP] 1-16 * abstract * * page 31606; table 1 *
SEARCH- SUN YAN-MEI ET AL, "Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X", BLOOD, (200512), vol. 106, no. 12, ISSN 0006-4971, pages 3811 - 3815, XP002377556 [XP] 1-16 * abstract * * page 3812, column L, paragraphs 3,5 * * page 3813; figure 2 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents